NCT01589861 2026-04-21
PIKHER2
Institut Paoli-Calmettes
Phase 1/2 Terminated
Clinical Trials
5 trialsNCT01118975 2019-11-13
GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers
University of Maryland, Baltimore
Phase 1/2 Terminated
NCT00953576 2018-09-04
KHLAD
Dana-Farber Cancer Institute
Phase 1/2 Terminated
NCT01495884 2015-10-26
The Myocet/Lapatinib Study. ICORG 10-03, V5
Cancer Trials Ireland
Phase 1/2 Terminated
NCT01658358 2013-02-27
ErbB2 Positive Metastatic Breast Cancer
China Medical University Hospital
Phase 1/2 Terminated